These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21393178)

  • 1. Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review.
    Cai Y; Chai D; Wang R; Bai N; Liang BB; Liu Y
    J Antimicrob Chemother; 2011 May; 66(5):968-78. PubMed ID: 21393178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of macrolides in bronchiectasis patients: a meta-analysis and systematic review.
    Shi ZL; Peng H; Hu XW; Hu JG
    Pulm Pharmacol Ther; 2014 Aug; 28(2):171-8. PubMed ID: 24076368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trials.
    Zhuo GY; He Q; Xiang-Lian L; Ya-Nan Y; Si-Te F
    Pulm Pharmacol Ther; 2014 Oct; 29(1):80-8. PubMed ID: 24594263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.
    Saiman L; Anstead M; Mayer-Hamblett N; Lands LC; Kloster M; Hocevar-Trnka J; Goss CH; Rose LM; Burns JL; Marshall BC; Ratjen F;
    JAMA; 2010 May; 303(17):1707-15. PubMed ID: 20442386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prolonged use of azithromycin in patients with cystic fibrosis: a meta-analysis.
    Florescu DF; Murphy PJ; Kalil AC
    Pulm Pharmacol Ther; 2009 Dec; 22(6):467-72. PubMed ID: 19328860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term daily high and low doses of azithromycin in children with cystic fibrosis: a randomized controlled trial.
    Kabra SK; Pawaiya R; Lodha R; Kapil A; Kabra M; Vani AS; Agarwal G; Shastri SS
    J Cyst Fibros; 2010 Jan; 9(1):17-23. PubMed ID: 19818694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of azithromycin and clarithromycin on macrolide susceptibility of viridans streptococci from the oral cavity of healthy volunteers.
    Eisenblätter M; Klaus C; Pletz MW; Orawa H; Hahn H; Wagner J; Lode H
    Eur J Clin Microbiol Infect Dis; 2008 Nov; 27(11):1087-92. PubMed ID: 18512087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin maintenance therapy in patients with cystic fibrosis: a dose advice based on a review of pharmacokinetics, efficacy, and side effects.
    Wilms EB; Touw DJ; Heijerman HG; van der Ent CK
    Pediatr Pulmonol; 2012 Jul; 47(7):658-65. PubMed ID: 22684985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of azithromycin in patients with cystic fibrosis.
    Samson C; Tamalet A; Thien HV; Taytard J; Perisson C; Nathan N; Clement A; Boelle PY; Corvol H
    Respir Med; 2016 Aug; 117():1-6. PubMed ID: 27492507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of erythromycin compared to clarithromycin and azithromycin in adults or adolescents with community-acquired pneumonia: A Systematic Review and meta-analysis of randomized controlled trials.
    Ashy N; Alharbi L; Alkhamisi R; Alradadi R; Eljaaly K
    J Infect Chemother; 2022 Aug; 28(8):1148-1152. PubMed ID: 35523718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa.
    Saiman L; Mayer-Hamblett N; Anstead M; Lands LC; Kloster M; Goss CH; Rose LM; Burns JL; Marshall BC; Ratjen F;
    Pediatr Pulmonol; 2012 Jul; 47(7):641-8. PubMed ID: 22684984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrolide antibiotics and the risk of cardiac arrhythmias.
    Albert RK; Schuller JL;
    Am J Respir Crit Care Med; 2014 May; 189(10):1173-80. PubMed ID: 24707986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial.
    Saiman L; Marshall BC; Mayer-Hamblett N; Burns JL; Quittner AL; Cibene DA; Coquillette S; Fieberg AY; Accurso FJ; Campbell PW;
    JAMA; 2003 Oct; 290(13):1749-56. PubMed ID: 14519709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [LONG TERM TREATMENT WITH MACROLIDES IN CHRONIC LUNG DISEASES].
    Shteinberg M; Schneer S; Lavon O; Adir Y
    Harefuah; 2016 Sep; 155(9):567-571. PubMed ID: 28530085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrolides in cystic fibrosis: is there a role?
    Wolter JM; Seeney SL; McCormack JG
    Am J Respir Med; 2002; 1(4):235-41. PubMed ID: 14720043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients.
    Principi N; Esposito S
    Drug Saf; 1999 Jan; 20(1):25-41. PubMed ID: 9935275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide antibiotic therapy in patients with cystic fibrosis.
    Schöni MH
    Swiss Med Wkly; 2003 May; 133(21-22):297-301. PubMed ID: 12861467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial.
    Altenburg J; de Graaff CS; Stienstra Y; Sloos JH; van Haren EH; Koppers RJ; van der Werf TS; Boersma WG
    JAMA; 2013 Mar; 309(12):1251-9. PubMed ID: 23532241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing COPD exacerbations with macrolides: a review and budget impact analysis.
    Simoens S; Laekeman G; Decramer M
    Respir Med; 2013 May; 107(5):637-48. PubMed ID: 23352223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resumption/efficacy and safety of an azithromycin-containing regimen against Mycobacterium avium complex lung disease in patients who experienced adverse effects with a clarithromycin-containing regimen.
    Kobayashi T; Tsuyuguchi K; Yoshida S; Kimura Y; Tsuji T; Minomo S; Kurahara Y; Inoue Y; Suzuki K
    Respir Investig; 2021 Mar; 59(2):212-217. PubMed ID: 33436352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.